How are research and development costs treated under GAAP?

• A. They are capitalized for future use
• B. They are expensed as incurred unless linked to developing an intangible asset
• C. They are disclosed only in footnotes
• D. They are treated as liabilities

Answer: (B)

Under GAAP (Generally Accepted Accounting Principles), research and development (R&D) costs are primarily treated as expenses incurred in the period in which they are recognized. This treatment is grounded in the principle that R&D activities do not provide a reliable basis for future economic benefits that can be capitalized.

Most research and development activities are inherently uncertain in terms of their outcomes and the associated future economic benefits. As such, treating these costs as expenses aligns with the matching principle of accounting, which requires expenses to be recorded in the same period as the revenues they help to generate.

However, there is an exception for costs associated with developing intangible assets if specific criteria are met. If an R&D project transitions into a development phase that results in identifiable and separable intangible assets, those associated costs may be capitalized and amortized over time.

This approach ensures that the financial statements reflect a clearer picture of a company's immediate financial performance and avoids inflating asset values with uncertain future cash flows from R&D expenditures.